f Urinary miRNAs and Prostate Cancer: Is there a Crossover Point Eventually, and where should we Head?

References

1. PayneH. CornfordP. Prostate-specific antigen: An evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer.Urol. Oncol.201129659360110.1016/j.urolonc.2009.11.003 20060331
   [Google Scholar]
2. RoehrbornC.G. The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia.Int. J. Impot. Res.200820S3Suppl. 3S19S2610.1038/ijir.2008.53 19002120
   [Google Scholar]
3. O’SheaA. HarisinghaniM. PI-RADS: Multiparametric MRI in prostate cancer.Magn. Reson. Mater. Biol. Phys. Med.202235452353210.1007/s10334‑022‑01019‑1 35596009
   [Google Scholar]
4. YoneyamaT. TobisawaY. KanekoT. KayaT. HatakeyamaS. MoriK. Sutoh YoneyamaM. OkuboT. MitsuzukaK. DuivenvoordenW. PinthusJ.H. HashimotoY. ItoA. KoieT. SudaY. GardinerR.A. OhyamaC. Clinical significance of the Lacdi NA c‐glycosylated prostate‐specific antigen assay for prostate cancer detection.Cancer Sci.201911082573258910.1111/cas.14082 31145522
   [Google Scholar]
5. ZiogouA. GiannakodimosA. GiannakodimosI. The role of urinary miRNAs in the diagnosis, management and follow-up of prostatic cancer.MicroRNA2023122838610.2174/2211536612666230324102850 36999432
   [Google Scholar]
6. GiannakodimosI. Urinary miRNAs as diagnostic biomarkers for prostatic cancer: Current dilemmas and novel potential role for a digital rectal examination.Curr. Med. Chem.202229254311431310.2174/0929867329666220118101733 35040397
   [Google Scholar]
7. PaivaR.M. ZauliD.A.G. NetoB.S. BrumI.S. Urinary microRNAs expression in prostate cancer diagnosis: A systematic review.Clin. Transl. Oncol.202022112061207310.1007/s12094‑020‑02349‑z 32323148
   [Google Scholar]
8. Casanova-SalasI. Rubio-BrionesJ. CalatravaA. MancarellaC. MasiáE. CasanovaJ. Fernández-SerraA. RubioL. Ramírez-BackhausM. ArmiñánA. Domínguez-EscrigJ. MartínezF. García-CasadoZ. ScotlandiK. VicentM.J. López-GuerreroJ.A. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.J. Urol.2014192125225910.1016/j.juro.2014.01.107 24518785
   [Google Scholar]
9. AvetaA. CilioS. ContieriR. SpenaG. NapolitanoL. ManfrediC. FrancoA. CrocerossaF. CerratoC. FerroM. Del GiudiceF. VerzeP. LasorsaF. SaloniaA. NairR. WalzJ. LucarelliG. PandolfoS.D. Urinary MicroRNAs as biomarkers of urological cancers: A systematic review.Int. J. Mol. Sci.202324131084610.3390/ijms241310846 37446024
   [Google Scholar]